Obesity is a heterogeneous condition requiring personalized clinical approaches and population-based solutions to address high-cardiovascular-risk forms, particularly excess visceral fat and severe obesity.
Recognizing the heterogeneity of obesity and targeting specific high-risk subgroups is essential for effective management in cardiovascular practice.
Obesity contributes to reduced life expectancy because of its link with type 2 diabetes and cardiovascular disease. Yet targeting this poorly diagnosed, ill-defined and under-addressed modifiable risk factor remains a challenge. In this review, we emphasize that the tendency among healthcare professionals to amalgam all forms of obesity altogether as a single entity may contribute to such difficulties and discrepancies. Obesity is a heterogeneous condition both in terms of causes and health consequences. Attention should be given to two prevalent subgroups of individuals: 1- patients who are overweight or moderately obese with excess visceral adipose tissue; and 2- patients with severe obesity, the latter group having distinct additional health issues related to their large body fat mass. The challenge of tackling high cardiovascular risk forms of obesity through a combination of personalized clinical approaches and population-based solutions is compounded by the current obesogenic environment and economy. Keywords: visceral obesity, massive obesity, ectopic fat deposition, cardiovascular disease, type 2 diabetes
Després et al. (Mon,) conducted a review in Obesity and cardiovascular disease. Management of obesity was evaluated. Obesity is a heterogeneous condition requiring personalized clinical approaches and population-based solutions to address high-cardiovascular-risk forms, particularly excess visceral fat and severe obesity.